Infinimmune
Industry
- Biotechnology
- Drug Discovery Technologies
- Genomics-Proteomics
- Large Molecule
- Antibodies
- Drug Discovery Technologies
- Pharmaceuticals
See more in Biomedtracker
Latest on Infinimmune
Scrip
• By Eleanor Malone
Pharma executives no longer ask whether AI is important in their industry – that much is certain, and it is already ubiquitous. As Lamine Mbow , global head of discovery research at Boehringer Ingelh
Scrip
• By Mandy Jackson
The end of 2023 is proving no different from the end of any other year, with venture capital firms and biopharmaceutical companies closing out a flurry of new VC funds and financings before December d
Scrip
• By Joseph Haas
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Organon Will Market Lilly’s Emgality, R